Apply the Cream : Take a small amount of the cream and apply it evenly on your face and neck
Avoid activities requiring mental alertness, such as driving, until you know how these medicines affect you
You must have either: Tried CPAP (used 4+ hours/night, 70%+ of nights) but still have symptoms, OR Can't use CPAP for medical reasons No diabetes your A1C (blood sugar test) must be 6.5% or lower Sleep specialist involvement must be prescribed by or in consultation with a sleep specialist Received counseling on sleep position and avoiding alcohol/sedatives before bed No planned surgeries for sleep apnea or weight loss Must be obstructive sleep apnea only not central or mixed types To keep coverage: After 12 months, you'll need to show at least 10% weight loss and improved sleep study scores to continue on Wegovy
Often hitting multiple biological pathways is a more effective medication strategy than hitting just one pathway very aggressively

If youre still experiencing symptoms: Get tested immediately - see a gastroenterologist Request a 4-hour gastric emptying scan Ensure results are properly documented Get formal written diagnosis If your symptoms have resolved: More difficult to prove you had gastroparesis Current testing may show normal emptying May still have a case if you have: Medical records documenting severe symptoms during active use Hospitalization records Endoscopy reports showing food retention Doctors notes discussing gastroparesis But case will be weaker without objective diagnostic test Bottom line for gastroparesis claims: Objective testing = required (gastric emptying scan) Clinical symptoms alone = not sufficient Test must show delayed emptying at 4-hour mark Get tested while symptomatic if possible For other injuries (bowel obstruction, vision loss): Different objective evidence is required: Bowel obstruction: CT scan, X-ray, surgical records NAION: Ophthalmologist diagnosis, visual field testing, OCT imaging Complete guide to gastric emptying scans and requirements

The ARF tumor suppressor targets PPM1G/PP2C to counteract NF-B transcription tuning cell survival and the inflammatory response